deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT00400179

A Safety and Efficacy Study in Patients With Gastric Cancer

An Open-Label Multicenter, Randomized, Phase 3 Study of S-1 in Combination With Cisplatin Against 5-Fu in Combination W/ Cisplatin in Patients W/ Advanced Gastric Cancer Previously Untreated W/ Chemotherapy for Advanced Disease

Sponsor: Quintiles, Inc.

Conditions Gastric Cancer
Updated 9 times since 2017 Last updated: Aug 30, 2024 Started: May 31, 2005 Primary completion: Mar 31, 2008 Completion: Apr 30, 2008
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Gastric Cancer and is currently completed. Quintiles, Inc. leads this study, which shows 9 recorded versions since 2005 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Sep 2020 · 27 months · monthly snapshotCompleted~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshotCompleted~Oct 2024 – ~Sep 2025 · 11 months · monthly snapshotCompleted~Sep 2025 – present · 11 months · monthly snapshotCompleted

Change History

9 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Oct 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Sep 2024 — Oct 2024 [monthly]

    Completed PHASE3

  4. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  5. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

Show 4 earlier versions
  1. Sep 2020 — Jan 2021 [monthly]

    Completed PHASE3

  2. Jun 2018 — Sep 2020 [monthly]

    Completed PHASE3

  3. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE3

  4. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE3

    First recorded

May 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Quintiles, Inc.
  • Taiho Oncology, Inc.
Data source: Taiho Oncology, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .